BiotechTube
Rouken Bio

Rouken Bio

London, United Kingdom· Est.
rouken.bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Rouken Bio is a privately held, UK-based preclinical CRO founded in 2020, focusing exclusively on immunology and regenerative medicine. It operates a service-based business model, leveraging state-of-the-art labs and a team of scientific experts to support client programs from discovery to clinical development. The company is in a revenue-generating stage, serving a global customer base across 25 countries, and is distinguished by a high Net Promoter Score (79) indicating strong client satisfaction. Its growth is evidenced by over 100 employees and expanding laboratory facilities.

ImmunologyRegenerative Medicine

Technology Platform

Integrated service platform combining deep immunology expertise, custom assay development, and state-of-the-art equipment for preclinical drug discovery and testing.

Opportunities

The growing complexity of immunology-based therapeutics (cell therapy, bispecifics) drives demand for specialized CRO expertise.
Global expansion and potential service line extension into adjacent areas like in vivo studies or biomarker validation present significant growth avenues.
High client satisfaction (NPS 79) fuels organic growth through referrals and repeat business.

Risk Factors

Revenue is vulnerable to downturns in biotech R&D funding and client budgets.
Intense competition from both large full-service CROs and other niche players requires constant innovation.
Operational risks include maintaining data quality and cultural integrity during rapid scaling, and potential reputational damage from project delays or failures.

Competitive Landscape

Rouken Bio competes in the specialized immunology CRO segment against other boutique firms and the niche service divisions of large, global CROs (e.g., Labcorp, Charles River). Its differentiation is its pure-play immunology focus, high-touch collaborative model, and strong client satisfaction metrics, which contrast with the often more transactional approach of larger competitors.

More companies in United Kingdom →